Aurora Cannabis (ACB) Free Cash Flow (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Free Cash Flow of $2.4 million for Q1 2026, up 117.4% year-on-year from $1.1 million in Q1 2025, and down 87.99% on a QoQ basis from $20.1 million in Q4 2025.
Aurora Cannabis (ACB) Free Cash Flow (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Free Cash Flow for 10 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow rose 117.4% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.5 million (up 200.8% YoY) and the FY2026 annual result came in at -$22.0 million, down 370.01% from the prior year.
- Free Cash Flow retreated to $2.4 million in Q1 2026 per ACB's latest filing, from $20.1 million in the prior quarter.
- Over the last five years, Free Cash Flow for ACB reached as high as $24.1 million in Q4 2024 and fell as low as -$78.5 million in Q4 2022.
- A 5-year average of -$14.2 million and a median of -$14.9 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 5314.51% — and 2024, when it jumped 1419.93%.
- Year by year, Free Cash Flow stood at -$78.5 million in 2022, then soared by 97.67% to -$1.8 million in 2023, then surged by 1419.93% to $24.1 million in 2024, then declined by 16.71% to $20.1 million in 2025, then slumped by 87.99% to $2.4 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $2.4 million, $20.1 million, and -$13.9 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 363.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Aurora Cannabis | 155.40 Mn | 70.15 Mn | 21.72 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Dec 31, 2025 | 20.09 Mn |
| Mar 31, 2025 | -13.87 Mn |
| Mar 31, 2025 | -13.87 Mn |
| Dec 31, 2024 | 24.12 Mn |
| Dec 31, 2024 | 24.12 Mn |
| Sep 30, 2024 | -14.92 Mn |
| Sep 30, 2024 | -14.92 Mn |
| Jun 30, 2024 | 12.14 Mn |
| Jun 30, 2024 | 12.14 Mn |
| Mar 31, 2024 | -36.53 Mn |
| Mar 31, 2024 | -36.53 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Sep 30, 2023 | -19.91 Mn |
| Sep 30, 2023 | -19.91 Mn |
| Dec 31, 2022 | -78.52 Mn |
| Dec 31, 2022 | -78.52 Mn |